Navigation Links
MAP Pharmaceuticals Reports No Difference in Pulmonary Artery Pressure Between LEVADEX™ and Placebo in Pharmacodynamics Trial
Date:9/8/2010

MOUNTAIN VIEW, Calif., Sept. 8 /PRNewswire-FirstCall/ -- MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) today reported results from a pharmacodynamics (PD) trial comparing the acute effects on pulmonary artery pressure of LEVADEX™, dihydroergotamine mesylate (DHE) administered intravenously (IV) and placebo. In the trial, there was no statistically significant difference between the LEVADEX and placebo groups in the primary endpoint of pulmonary artery pressure over two hours after administration. LEVADEX is a novel orally inhaled migraine therapy that has completed Phase 3 efficacy development for the acute treatment of migraine.

LEVADEX was well tolerated and there were no drug-related serious adverse events reported. There were no clinically significant changes in any cardiovascular parameters measured in this trial. There were no mean increases in QT interval in the LEVADEX group. All pharmacokinetic results in this trial were consistent with those reported in previous LEVADEX trials."Intravenous DHE has been used safely for over 60 years, and we wanted to evaluate whether LEVADEX, with its novel administration through the lung, would have an effect on pulmonary artery pressure. We are pleased to report that LEVADEX did not have an effect on pulmonary artery pressure compared to placebo and was, in fact, less than that seen with IV DHE," said Timothy S. Nelson, president and chief executive officer of MAP Pharmaceuticals.

Pulmonary artery pressure in the IV DHE group was higher than both the LEVADEX and placebo groups. In addition, even after a second dose of LEVADEX was administered two hours after the first dose, pulmonary artery pressure was not higher in the LEVADEX group than in the IV DHE group.  

The PD trial was a randomized, double blind, placebo controlled, three-way, crossover trial in 24 healthy adults and was designed to compare the acute e
'/>"/>

SOURCE MAP Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Isis Pharmaceuticals to Present at the Stifel Nicolaus 2010 Healthcare Conference
2. MAP Pharmaceuticals Announces All Non-Asthmatic Patients Complete Treatment in Open-Label Trial and Completion of Treatment in QT Trial for LEVADEX™ Clinical Program
3. Transcept Pharmaceuticals to Present at Rodman & Renshaw and Stifel Nicolaus Investor Conferences in September 2010
4. Cadence Pharmaceuticals to Present at Four Investment Conferences During the Month of September 2010
5. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
6. MAP Pharmaceuticals to Present at Upcoming Healthcare and Scientific Conferences
7. Tibotec Pharmaceuticals Seeks European Marketing Authorization for Investigational Once-Daily HIV Treatment TMC278
8. Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification
9. Transdel Pharmaceuticals Presents Phase 3 Study Data on Ketotransdel® at World Pain Congress in Montreal, Canada
10. Optimer Pharmaceuticals Announces Presentations of Additional Fidaxomicin Phase 3 Data at Upcoming ICAAC Annual Meeting
11. Optimer Pharmaceuticals to Present at September 2010 Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... , July 22, 2014 The National Space ... the Center for Space Radiation Research (CSRR) under the ... is an Associate Professor of Pharmaceutical Sciences within the ... Pharmacy Division of Radiation Health. She is located in ... direct a team of investigators working across four U.S. ...
(Date:7/22/2014)... 22, 2014  Decision Resources Group finds that ... patients currently treated with Biogen Idec,s oral ... flushing and/or gastrointestinal events while on the ... experiencing these side effects, signifying either their ... of such events. In the end, fewer ...
(Date:7/22/2014)... , July 22, 2014  Eyeon Therapeutics has ... eye treatment based on a charged hydrophilic polymer developed ... product has been shown to be safe and effective ... , MD, CEO states, "This first set of claims ... long way to moving this technology into the commercial ...
Breaking Medicine Technology:Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 2Boerma Led UAMS Team to Establish NSBRI's Center for Space Radiation Research (CSRR) 3Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 2Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted 3Particle Sciences and Eyeon Therapeutics Receive Patent on Novel Dry Eye Technology 2
... - Fralex Therapeutics Inc.,(TSX:FXI) ("Fralex" or the "Company"), ... today provided an update,on receiving results of the ... is investigating the use of Complex Neural Pulse ... associated with fibromyalgia., The Independent Data Monitoring ...
... from a 52-week phase 3,study (LEADTM 3) of ... once-daily,human GLP-1 analog, were published online today in ... alone, produces statistically,significant and sustained improvements in blood ... as compared with glimepiride, a widely used,oral anti-diabetic ...
Cached Medicine Technology:Fralex provides update on timing of interim analysis results 2Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet 2Data from One-Year Liraglutide Phase 3 Study Published Online in The Lancet 3
(Date:7/23/2014)... Hills, CA (PRWEB) July 23, 2014 ... 90 million Americans suffering from chronic bad breath that the ... whom they speak. , Dr. Saj Jivraj and Dr. Mamaly ... Woodland Hills, Calif., are concerned that some people may be ... breath often is a sign of an infection or chronic ...
(Date:7/23/2014)... QueenBeeTickets.com is reducing the prices of History of The Eagles ... who are still in the process of looking for concert ... use promo code “DISCOUNT” to get even lower prices than ... of discounted tickets at QueenBeeTickets.com. , The phenomenal band will ... The Eagles concert tickets literally disappearing across the country. The ...
(Date:7/23/2014)... 23, 2014 There is inherently nothing ... that it is healthy enough to react to specific ... “washing out” harmful toxins and bacteria from the body ... body just cannot do. , However, the social ... commonly known as “excessive sweating”—are serious: since sweating itself ...
(Date:7/23/2014)... Online medical service provider MeMD has appointed Dr. ... Dr. Lorenzo joins the MeMD executive team with over 25 ... part of this remote treatment model, telemedicine. This is the ... medical school, that someday we could treat people across the ... and it hasn't been that long,” says Dr. Lorenzo. , ...
(Date:7/23/2014)... viewed with suspicion as a New Age indulgence or ... business and arguably the most successful segment of health ... Die , award-winning journalists Fran Smith and Sheila Himmel ... their families. It’s the first book to take a ... of patients, caregivers and cutting-edge researchers, as well as ...
Breaking Medicine News(10 mins):Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 2Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 3Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 4Health News:Woodland Hills’ Top Cosmetic Dentists Offer 6 Tips on Causes of Bad Breath That Should Concern You 5Health News:History of The Eagles Tour Tickets: QueenBeeTickets.com Reduces Prices on Remaining Inventory of Concert Tickets for 2014 Shows 2Health News:Beat Your Sweating Demons Review | The Problem With Excessive Sweating and Solving it Naturally – Vinamy.com 2Health News:Beat Your Sweating Demons Review | The Problem With Excessive Sweating and Solving it Naturally – Vinamy.com 3Health News:Telemedicine Provider MeMD Announces Nicholas Lorenzo, MD, MHCM, CPE as Chief Medical Officer 2Health News:Telemedicine Provider MeMD Announces Nicholas Lorenzo, MD, MHCM, CPE as Chief Medical Officer 3Health News:Dealing with Loss: Library Journal Calls Changing the Way We Die an Essential Read 2
... hit Western Australia's south region with 50 cases being reported ... has also been // reported in the Territories with another ... ,Entomologist Nina Kurucz said that the pre-monsoon rains have ... is that this sort of mosquito can fly up to ...
... Professor Robin Simon and colleagues from Florida State University ... Behavior the reports of their study// conducted in ... had plans of not having children’s experienced less depression ... claims controversies views expressed by earlier researchers who had ...
... determining mental health status of an individual according to ... fatty food and compromise on fresh food such as ... memory related problems. Moreover, implementation of diet changes was ... than conventional approaches such as drug treatment or counseling. ...
... to treat breast cancer reduces the radiation time from six weeks ... it is less convenient. Doctors// can point the radiation ... study compares the usefulness of the new therapy over the conventional ... suitable subjects for this therapy. ,But the Canadians are ...
... a workshop on Islamic Medical Ethics new rules and ... was attended by national and international physicians who wanted ... Malika Haque, Clinical Professor Pediatrics, Ohio State University and ... several new ethical laws. ,They said ...
... Jong S. Kim and his colleagues from Asan medical ... drug Prozac is found effective in treating emotional stress ... conducted their study in 152 patients who were given ... months and the results found that the study patients ...
Cached Medicine News:Health News:Diet Can Influence Your Mental Health As Well 2
Velcro closures on each side to more evenly distribute the weight. Available in teal, royal, red, purple, or maroon nylon stain-resistant fabric or navy nylon reinforced vinyl....
Our quick release buckle apron is user friendly and our large support straps criss-crossing the back allows proper placement of the belt at your waist. Built-in shoulder pads add to the comfort....
An economical solution to the need to provide wrap-around protection. The one-sided velcro closure allows greater flexibility in sizing. Front protection is 0.5mm Pb and the back is 0.25mm Pb equival...
The most comfortable and easy to use apron in the industry. This front protection apron comes with a fully adjustable snap-on 5" orthopedic belt to relieve weight off your shoulders. Velcro strap acr...
Medicine Products: